Predicting novel candidate human obesity genes and their site of action by systematic functional screening in Drosophila.
Neha AgrawalKatherine LawlerCatherine M DavidsonJulia M KeoghRobert G Leggnull nullInês A BarrosoI Sadaf FarooqiAndrea H BrandPublished in: PLoS biology (2021)
The discovery of human obesity-associated genes can reveal new mechanisms to target for weight loss therapy. Genetic studies of obese individuals and the analysis of rare genetic variants can identify novel obesity-associated genes. However, establishing a functional relationship between these candidate genes and adiposity remains a significant challenge. We uncovered a large number of rare homozygous gene variants by exome sequencing of severely obese children, including those from consanguineous families. By assessing the function of these genes in vivo in Drosophila, we identified 4 genes, not previously linked to human obesity, that regulate adiposity (itpr, dachsous, calpA, and sdk). Dachsous is a transmembrane protein upstream of the Hippo signalling pathway. We found that 3 further members of the Hippo pathway, fat, four-jointed, and hippo, also regulate adiposity and that they act in neurons, rather than in adipose tissue (fat body). Screening Hippo pathway genes in larger human cohorts revealed rare variants in TAOK2 associated with human obesity. Knockdown of Drosophila tao increased adiposity in vivo demonstrating the strength of our approach in predicting novel human obesity genes and signalling pathways and their site of action.
Keyphrases
- weight loss
- insulin resistance
- adipose tissue
- endothelial cells
- metabolic syndrome
- genome wide
- weight gain
- type diabetes
- bariatric surgery
- induced pluripotent stem cells
- copy number
- high fat diet induced
- high fat diet
- stem cells
- bioinformatics analysis
- dna methylation
- gene expression
- spinal cord injury
- small molecule
- high throughput
- young adults
- glycemic control
- mesenchymal stem cells
- spinal cord
- binding protein
- protein protein